{
  "docId": "019de516-de84-709f-9864-0c2e708269aa",
  "docSlug": "d2a0e3b4a50bc196c7afb3f2c93e5906",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 38 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 38,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 36,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-de84-709f-9864-0c2e708269aa/10",
  "deckHref": "/decks/019de516-de84-709f-9864-0c2e708269aa",
  "deckJsonHref": "/decks/019de516-de84-709f-9864-0c2e708269aa.json",
  "deckAnchorHref": "/decks/019de516-de84-709f-9864-0c2e708269aa#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.766,
        "x": 0.15,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "1. Products with sales outside the United States impacted by F/X changes. 2. This is a non-GAAP measure or ratio. See Slide 1 and Appendix for further information on non-GAAP measures and ratios. 3. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the reported results of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar products. The net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34708a89-e14b-4be6-9df3-c53f6d973b4f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.71,
        "w": 0.909,
        "x": 0.045,
        "y": 0.16
      },
      "kind": "table",
      "text": "Bausch + Lomb 3Q23 3Q22 Reported Change Constant Currency Change2 Vision Care Revenue3 $648M $597M 9% 11% Surgical Revenue $185M $172M 8% 6% Pharmaceuticals Revenue3 $174M $173M 1% 1% Total Revenue $1,007M $942M 7% 8% Gross Profit $568M $510M 11% 14% Gross Margin 56.4% 54.1% 230 bps R&D $82M $77M (6%) (5%) R&D % of Revenue 8.1% 8.2% SG&A $418M $381M (10%) (10%) SG&A % of Revenue 41.5% 40.4% Operating Income $40M $46M Net Loss Attributable to B+L ($84M) ($18M) Net Loss Margin (8.3%) (1.9%) EPS Attributable to B+L ($0.24) ($0.05)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c59347e0-0a20-46fe-a3d5-575f151dc143",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.602,
        "x": 0.045,
        "y": 0.07
      },
      "kind": "title",
      "text": "3Q23 Total Bausch + Lomb P&L¹ (GAAP)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "daa5a4bd-8703-4303-bbf4-8ee542ca5ff8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 12,
      "from": 9,
      "beatId": "b9cf5ce1-b685-45e0-9608-f105481e9d46",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The deck provides an outlook on future growth and raised guidance.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 5,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "03b15dcd-2f58-41ce-b199-e78db7aa1af4",
      "evidence": "The deck presents a logical chain of revenue growth, growth drivers, and strategic initiatives.",
      "position": 0,
      "objective": "How will Bausch + Lomb's strategic initiatives drive growth?",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}